Sign up


Match Document Document Title
US20130324587 Factors Controlling Skin and Hair Color  
Use of autophagic activity in regulation of the amount of melanin in a keratinocyte, the control of skin or hair color, or selection of an agent for regulating the amount of melanin in a...
US20130243713 Skin and Hair Color-Controlling Factor  
Provided are a gene involved in the regulation of the amount of melanin in keratinocytes, and the control of the color of skin or hair, the gene being selected from the group consisting of ATG7...
US20140171359 DIAGNOSIS OF RESPIRATORY TRACT INFECTIOUS DISEASES USING URINE SPECIMENS  
Provided are a method for detecting respiratory infection associated with bacterial infection, a method for selecting patients with respiratory infection to receive an antibiotic, and a method for...
US20110002904 SYNOVIAL VILLI FOR USE WITH TISSUE ENGINEERING  
Synovial villi derived explants and related surgical tools used to repair or prevent damage to injured or diseased tissue, including connective tissue. The tools including a harvesting tool for...
US20110281338 NITRATE-REMOVING BIOREACTOR, METHOD FOR FORMING NITRATE-REMOVING BIOFILM, AND NITRATE-REMOVING METHOD  
Disclosed is a bioreactor which is capable of efficiently removing nitrate ions. A nitrate-removing bioreactor (1) comprises a reaction container (2) and an introduction part (3) for introducing a...
US20140242111 Engineered Bacteria for Oral Delivery of Glucoregulatory Proteins  
Disclosed is an oral delivery system that overcomes major barriers encountered in the gastrointestinal tract, particularly rapid proteolytic degradation and low intestinal permeability. Provided is...
US20120029074 CONTROLLING TRANSGENE EXPRESSION ACROSS THE SKIN  
The invention relates to the use of a skin permeating compound such as phloretin for controlling transgene expression under control of the Pseudomonas putida DOT-T1E-derived bacterial repressor...
US20130029371 DISK DIFFUSION ASSAY FOR ORITAVANCIN  
The present invention is directed to a disk diffusion assay for determining susceptibility of bacteria to a glycopeptide antibiotic. The assay includes improvements over conventional assays due to...
US20140186950 SYNTHETIC MEMBRANE ANCHORS  
Cells incorporating a synthetic molecule construct of the structure F—S1—S2-L where: F—S1 is an aminoalkylglycoside where F is a mono-, di-, tri- or oligo-saccharide and S1 is 2-aminoethyl, 3-ami...
US20130280797 MICROSCALE BIOPROCESSING SYSTEM AND METHOD FOR PROTEIN MANUFACTURING  
A bioprocessing system for protein manufacturing is provided that is compact, integrated and suited for on-demand production and delivery of therapeutic proteins to patients. The system can also be...
US20100310586 IDIOTYPIC VACCINE  
The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of...
US20110117131 Production of OspA for Lyme Disease Control  
The present invention relates, generally, to the production of one or more OspA proteins in plant cells. Heterologous DNA comprising genes encoding one or more desired OspA protein(s) are...
US20130116343 Salivary Protein Markers for Detection of Breast Cancer  
A method of diagnosing a patient's risk of breast cancer comprises measuring in a saliva sample from the patient a concentration of at least a first protein marker, wherein the first protein marker...
US20110171654 Allelic ladder loci  
Disclosed are rare short tandem repeat (STR) alleles within the D10S1248 and D12S391 loci in humans. Provided are representative allelic ladders for each locus, methods and assays using these...
US20140017682 HIGH RESOLUTION MELTING ANALYSIS AS A PRESCREENING TOOL  
Compositions and methods for determining an increased likelihood of a response to a targeted treatment of a cancer disease including isolating genomic DNA from a patient sample, amplifying a...
US20140213507 DIAGNOSIS OF RESPIRATORY TRACT INFECTIOUS DISEASE USING BLOOD SPECIMENS  
Provided are a method for detecting respiratory infection associated with bacterial infection, a method for selecting patients with respiratory infection to receive an antibiotic, and a method for...
US20130219556 Viral Based Transient-Expression Vector System That Allows Multiple Applications  
Disclosed herein are viral vectors suitable for transfection into woody trees for purposes of delivering and expressing beneficial genes. Specifically exemplified herein are vectors for...
US20120204287 VIRAL BASED TRANSIENT-EXPRESSION VECTOR SYSTEM THAT ALLOWS MULTIPLE APPLICATIONS  
Disclosed herein are viral vectors suitable for transfection into woody trees for purposes of delivering and expressing beneficial genes. Specifically exemplified herein are vectors for...
US20120115154 REFERENCE MARKERS FOR BIOLOGICAL SAMPLES  
DNA oligomers comprising sequences that are absent from the genome of one or more organisms of interest are used as reference markers (RMs). The RMs are added to biological samples to “tag” and sub...
US20130005005 Modified Lipids Produced from Oil-Bearing Microbial Biomass and Oils  
Chemically modified lipids and methods for their preparation are provided.
US20120028879 HIGHLY SENSITIVE DETECTION METHOD FOR HIGHLY VIRULENT ORAL CAVITY BACTERIA  
Provided is a method that involves the detection of protein antigen (PA) and/or collagen-binding protein (CBP) of oral cavity bacteria in a sample, and in which oral cavity bacteria that exacerbate...
US20130096052 PROCALCITONIN FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS AND GUIDANCE OF ANTIBIOTIC TREATMENT IN PATIENTS WITH NON-SPECIFIC COMPLAINTS  
The present invention relates to the determination of the level of marker peptides in a sample derived from a bodily fluid of a subject presenting with non-specific complaints.
US20140105886 ASSOCIATION OF BIOMARKERS WITH PATIENT OUTCOME  
Glioblastoma multiforme (GBM) is an aggressive form of brain cancer. Biomarkers for GBM that provide prognostic and predictive information are useful because they provide the physician valuable...
US20140349340 MBTH-LIKE PROTEINS IN THE PRODUCTION OF SEMI SYNTHETIC ANTIBIOTICS  
The present invention relates to the preparation of β-lactam antibiotics comprising contacting 4-hydroxyphenylglycine or phenylglycine, cysteine and valine with a non-ribosomal peptide synthetase ...
US20130274114 MULTIPOTENT STEM CELL-BASED CULTURE SYSTEMS AND MODELS  
This invention generally relates to multipotent stem cell-based research tools. More particularly, the present invention relates to culture systems and 3-dimensional tissue models that may be used...
US20140274777 LIPID DROPLET PROTEIN MARKERS FOR ALGAL OIL ACCUMULATION  
The application relates to apparatuses, methods and kits for detecting and quantifying oil content in algal samples.
US20110033879 DIRECT ASSAY OF CHOLESTEROL IN SKIN REMOVED BY TAPE STRIPPING  
Skin cholesterol is measured by applying an adhesive tape onto a selected area of the skin to adhere the tape to the selected skin area and stripping the tape off the selected skin area to obtain a...
US20120276145 EXTRACELLULAR MATRIX PROTEINS FROM HAEMOPHILUS INFLUENZAE BIOFILMS: TARGETS FOR THERAPEUTIC OR DIAGNOSTIC USE  
A method of identifying a biofilm that includes non-typeable Haemophilus influenza (NTHi) including a step of screening a sample for the presence of one or more biofilm-specific proteins that are...
US20140242698 MEDICAL RECORDS STORAGE SYSTEM  
Electronic medical records have to evolve from the isolated hospital systems or insurance company owned storage data silos based on a binary code accessed by patients through portals to the patient...
US20110059445 MUCOSAL GENE SIGNATURES  
Infliximab (IFX) is an effective treatment for Crohn's disease (CD) and ulcerative colitis (UC) not responding to standard therapy. Thirty percent to forty percent of patients however do not...
US20130230555 SYNTHETIC LIPID BIOLOGY FOR COMBINATORIAL ENGINEERING OF ENDOTOXIN  
The present disclosure generally relates to genetic engineering of bacteria. More particularly, the present disclosure relates to genetic engineering of Gram-negative bacteria expressing different...
US20130143281 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof  
Disclosed are chimeric polyunsaturated fatty acid (PUFA) olyketide synthase (PKS) proteins and chimeric PUFA PKS systems, including chimeric PUFA PKS proteins and systems derived from...
US20120021470 Chimeric PUFA Polyketide Synthase Systems and Uses Thereof  
Disclosed are chimeric polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) proteins and chimeric PUFA PKS systems, including chimeric PUFA PKS proteins and systems derived from...
US20140220564 TT1 AND TTG1 Control Seed Coat Color In Brassica  
Seed coat color is a very important trait in oilseed type Brassica crops. Identification of the genes controlling the seed coat color is essential to the manipulation of these genes to develop new...
US20120315638 Moisture-Activated Self-Heating Analysis Device  
Provided are disposable, moisture-activated, self-heating cartridges useful for, e.g., isothermal nucleic acid amplification, incubation, and thermal actuation, and visual fluorescent detection of...
US20110171315 Oral recombinant helicobacter pylori vaccine and preparing method thereof  
The invention relates to a recombinant protein used for immunoprophylaxis of human Helicobacter pylori infection and a degradable slow-releasing microsphere-encapsulated oral vaccine preparation...
US20110305777 DIMERIC IAP ANTAGONISTS  
Smac mimetics that inhibit IAPs.
US20130238092 Composite for Thermo-Sensitive Cell-Tissue Transplanted Scaffold and Use thereof  
A composite comprising a stem cell; a biodegradable layer, which can provide an environment for the stem cell to grow and to differentiate, and; a N-isopropylacrylamide (NIPAAm), which can...
US20130252317 PROCESS FOR THE ENZYMATIC PURIFICATION OF OILS OF VEGETABLE OR ANIMAL ORIGIN  
A method for the enzymatic breakdown of phosphorus-containing constituents and glycosides, in particular steryl glycoside, from crude oil or pre-degummed oil of vegetable or animal origin, wherein...
US20130309204 VEGETABLE OILS AS NITROGEN FIXING BACTERIA PRESERVATIVE  
Methods of preserving the life span of nitrogen-fixing bacteria in agricultural pesticide formulations using vegetable oils.
US20120021497 HYDRODYNAMIC EXTRACTION OF OILS FROM PHOTOSYNTHETIC CULTURES  
The presently described invention relates to the method of extraction of oils from photosynthetic cultures using hydrodynamic cavitation technology for the production of biofuels or other products....
US20130274441 General Method for Designing Self-Assembling Protein Nanomaterials  
Methods and systems for computationally designing self-assembling polypeptides are disclosed. A representation of a docked configuration of a symmetric protein architecture can be determined by a...
US20140106390 BIOMARKERS FOR THE TREATMENT OF MULTIPLE MYELOMA  
Provided herein are the biomarkers for predicting or monitoring the efficacy of a treatment for multiple myeloma. The use of certain M-protein or other protein levels as biomarkers to predict...
US20130195958 PROCESS FOR THE PRODUCTION OF PATCHES OR DERSSINGS OF AUTOLOGOUS SKIN THROUGH CULTIVATION OF AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS WITH AUTOLOGOUS SERUM FOR THE GENERATION OF SKIN  
The process in general is based on taking a sample of skin and a sample of blood from the patient and based on these two elements skin is cultured, being placed on a collagen patch to produce a...
US20130052673 USE OF ENZYME EMULSION THICKNESS TO AFFECT CALIBRATION CODE FACTORS IN TEST STRIP MANUFACTURING  
The invention provides a method of controlling the slope, intercept and bias for a batch of test strips by increasing or decreasing the enzyme pad height of the strips. The invention provides an...
US20140271542 GENETIC MARKER FOR PREDICTING PROGNOSIS IN PATIENTS INFECTED WITH HEPATITIS C VIRUS  
The present invention provides methods and materials for predicting the clinical outcome of a hepatitis C virus (HCV) infection. In particular, the invention relates to methods and materials for...
US20140273074 YEAST SCREENS FOR TREATMENT OF HUMAN DISEASE  
Screening methods for identifying substances that provide therapeutic value for various diseases associated with protein misfolding are provided. Genetic and chemical screening methods are provided...
US20130005608 YEAST SCREENS FOR TREATMENT OF HUMAN DISEASE  
Screening methods for identifying substances that provide therapeutic value for various diseases associated with protein misfolding are provided. Genetic and chemical screening methods are provided...
US20110300533 Yeast Screens for Treatment of Human Disease  
Screening methods for identifying substances that provide therapeutic value for various diseases associated with protein misfolding are provided. Genetic and chemical screening methods are provided...
US20110206765 Non-Typeable Haemophilus Influenzae Vaccines and Their Uses  
Provided are non-typeable Haemophilus influenzae vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a...